Andreas Pinter (A Pinter)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 67

Top Topics

Atopic Dermatitis

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Dermatology and therapy

The British journal of dermatology

Rheumatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Pinter, Ahmed M Soliman, Irina Pivneva, Roksana Ghanbariamin, Min Yang, Cong Bang Truong, Lluis L Puig, Mark Lebwohl
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study. Dermatology and therapy 14 (5) (2024)
Andreas Pinter, A Costanzo, S Khattri, S D Smith, J M Carrascosa, Y Tada, E Riedl, A Reich, A Brnabic, N Haustrup, A Lampropoulou, I Lipkovich, Z Kadziola, C Paul, C Schuster
Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and therapy (2024)
Andreas Pinter, Ahmed M Soliman, Karina C Manz, Valeria Weber, Paul Ludwig, Anja Mocek, Ariane Höer, Mark G Lebwohl
Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data. Dermatology and therapy 14 (6) (2024)
Iris Verbinnen, Emilio Monte-Boquet, Detlev Parow, Fabienne Lacombe, Andrew Pothecary, Arno W R van Kuijk, Laura Harrington, Edita Müllerová, Andreas Pinter, Ulrike Erstling, Andrea Tomasini, Philip S Helliwell
Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative. Rheumatology and therapy 11 (3) (2024)
Iris Verbinnen, Emilio Monte-Boquet, Detlev Parow, Fabienne Lacombe, Andrew Pothecary, Arno W R van Kuijk, Laura Harrington, Edita Müllerová, Andreas Pinter, Ulrike Erstling, Andrea Tomasini, Philip S Helliwell
Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative. Rheumatology and therapy 11 (3) (2024)
Andreas Pinter, Ahmed M Soliman, Irina Pivneva, Roksana Ghanbariamin, Min Yang, Cong Bang Truong, Lluis L Puig, Mark Lebwohl
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study. Dermatology and therapy 14 (5) (2024)
Iris Verbinnen, Emilio Monte-Boquet, Detlev Parow, Fabienne Lacombe, Andrew Pothecary, Arno W R van Kuijk, Laura Harrington, Edita Müllerová, Andreas Pinter, Ulrike Erstling, Andrea Tomasini, Philip S Helliwell
Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative. Rheumatology and therapy 11 (3) (2024)
Andreas Pinter, Ahmed M Soliman, Karina C Manz, Valeria Weber, Paul Ludwig, Anja Mocek, Ariane Höer, Mark G Lebwohl
Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data. Dermatology and therapy 14 (6) (2024)
Andreas Pinter, Ahmed M Soliman, Karina C Manz, Valeria Weber, Paul Ludwig, Anja Mocek, Ariane Höer, Mark G Lebwohl
Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data. Dermatology and therapy 14 (6) (2024)
Andreas Pinter, Ahmed M Soliman, Karina C Manz, Valeria Weber, Paul Ludwig, Anja Mocek, Ariane Höer, Mark G Lebwohl
Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data. Dermatology and therapy 14 (6) (2024)
Stephan Traidl, Luise Heinrich, Doreen Siegels, Annice Heratizadeh, Barbara Kind, Eva Haufe, Susanne Abraham, Thomas Schäfer, Matthias Augustin, Inken Harder, Andreas Pinter, Knut Schäkel, Andreas Wollenberg, Konstantin Ertner, Jutta Ramaker-Brunke, Anne Bong, Sven Quist, Hannah Gorriahn-Maiterth, Florian Schenck, Michael Sticherling, Isaak Effendy, Beate Schwarz, Christiane Handrick, Andrea Asmussen, Stephan Weidinger, Jochen Schmitt, Thomas Werfel, null null
Treatment of moderate-to-severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Stephan Traidl, Moritz M Hollstein, Nadine Kroeger, Sascha Fischer, Annice Heratizadeh, Luise Heinrich, Barbara Kind, Doreen Siegels, Susanne Abraham, Thomas Schäfer, Matthias Augustin, Inken Harder, Andreas Pinter, Knut Schäkel, Andreas Wollenberg, Konstantin Ertner, Jutta Ramaker-Brunke, Anne Bong, Sven Quist, Hannah Gorriahn-Maiterth, Florian Schenck, Michael Sticherling, Isaak Effendy, Beate Schwarz, Christiane Handrick, Andrea Asmussen, Stephan Weidinger, Jochen Schmitt, Thomas Werfel, null null
Obesity is linked to disease severity in moderate to severe atopic dermatitis-Data from the prospective observational TREATgermany registry. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Andreas Pinter, Ahmed M Soliman, Irina Pivneva, Roksana Ghanbariamin, Min Yang, Cong Bang Truong, Lluis L Puig, Mark Lebwohl
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study. Dermatology and therapy (2024)
Iris Verbinnen, Emilio Monte-Boquet, Detlev Parow, Fabienne Lacombe, Andrew Pothecary, Arno W R van Kuijk, Laura Harrington, Edita Müllerová, Andreas Pinter, Ulrike Erstling, Andrea Tomasini, Philip S Helliwell
Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative. Rheumatology and therapy (2024)
Andreas Pinter, Ahmed M Soliman, Karina C Manz, Valeria Weber, Paul Ludwig, Anja Mocek, Ariane Höer, Mark G Lebwohl
Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data. Dermatology and therapy (2024)
Iris Verbinnen, Emilio Monte-Boquet, Detlev Parow, Fabienne Lacombe, Andrew Pothecary, Arno W R van Kuijk, Laura Harrington, Edita Müllerová, Andreas Pinter, Ulrike Erstling, Andrea Tomasini, Philip S Helliwell
Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative. Rheumatology and therapy 11 (3) (2024)
Andreas Pinter, A Costanzo, S Khattri, S D Smith, J M Carrascosa, Y Tada, E Riedl, A Reich, A Brnabic, N Haustrup, A Lampropoulou, I Lipkovich, Z Kadziola, C Paul, C Schuster
Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and therapy (2024)
Andreas Pinter, Ahmed M Soliman, Irina Pivneva, Roksana Ghanbariamin, Min Yang, Cong Bang Truong, Lluis L Puig, Mark Lebwohl
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study. Dermatology and therapy 14 (5) (2024)
Andreas Pinter, A Costanzo, S Khattri, S D Smith, J M Carrascosa, Y Tada, E Riedl, A Reich, A Brnabic, N Haustrup, A Lampropoulou, I Lipkovich, Z Kadziola, C Paul, C Schuster
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and therapy 14 (6) (2023)
Lars Iversen, Curdin Conrad, Liv Eidsmo, Antonio Costanzo, Joanna Narbutt, Andreas Pinter, Külli Kingo, Raquel Rivera-Díaz, Frank Kolbinger, ManikPrabhu Nanna, Jennifer Annika Frueh, Piotr Jagiello
Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Bruno Halioua, G Caillet, Charles Taïeb, A Bewley, A Snel-Prentø, M Praestegaard, A Armstrong, Andreas Pinter
A novel calcipotriol and betamethasone dipropionate (CAL/BDP) PAD-cream demonstrates greater improvements in daily activities and personal relationships than CAL/BDP gel/TS: a post-hoc analysis of DLQI outcomes from two phase 3 placebo-controlled randomized clinical trials in mild-to-moderate psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Andreas Pinter, Linda F Stein Gold, Adam Reich, Lawrence J Green, Morten Praestegaard, Johan Selmer, April W Armstrong, Anne Danø, Sunil Dhawan, Jordi Galván, Sandra Elkjaer Stallknecht, Paw Trebbien, Matthias Augustin
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30 th EADV Congress 2021. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Andreas Pinter, A Costanzo, S Khattri, S D Smith, J M Carrascosa, Y Tada, E Riedl, A Reich, A Brnabic, N Haustrup, A Lampropoulou, I Lipkovich, Z Kadziola, C Paul, C Schuster
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and therapy (2023)
Joseph Frank Merola, Albert S Chiou, Emmanuel H During, Antonio Costanzo, Peter Foley, Amani Alfalasi, Shaila Gogate, Andreas Pinter, Roni P Dodiuk-Gad, Dagmar Simon, Marie Tauber, Richard B Weller, José Juan Pereyra-Rodriguez, Marius Ardeleanu, Jiangming Wu, Zafer E Ozturk
Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase 4 randomized double-blinded placebo-controlled DUPISTAD study. The British journal of dermatology (2023)
Nina Magnolo, Thomas Jaenicke, Athanasios Tsianakas, Wolfgang Czech, Diamant Thaҫi, Andreas Pinter, Delphine Kerob, Samir Salah, Thomas A Luger
Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Tiago Torres, Jordi Galván, Nigel Crutchley, Morten Praestegaard, Lars Iversen, Paolo Gisondi, Y José Manuel Carrascosa, Bruno Halioua, Anthony Bewley, Andreas Pinter
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review. Dermatology and therapy (2023)
Knut Schäkel, Kristian Reich, K Asadullah, Andreas Pinter, Denis Jullien, P Weisenseel, C Paul, M Gomez, S Wegner, Y Personke, F Kreimendahl, Yanqing Chen, J Angsana, M W L Leung, K Eyerich
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Adam Reich, Andreas Pinter, Julia-Tatjana Maul, Ronald B Vender, Tiago Torres, A Brnabic, Natalie Haustrup, C Reed, C Schuster, E Riedl
Speed of clinical improvement in the real-world setting from patient-reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Sebastian Kiefer, Anke König, Viviane Gerger, Christine Rummenigge, Anne Christine Müller, Thomas Jung, Alexandra Frank, Georgios Tassopoulos, Emilie Laurent, Roland Kaufmann, Andreas Pinter
Efficacy and Treatment Satisfaction of Different Systemic Therapies in Children and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Real-World Study. Journal of clinical medicine 12 (3) (2023)
Lars Iversen, Curdin Conrad, Liv Eidsmo, Antonio Costanzo, Joanna Narbutt, Andreas Pinter, Külli Kingo, Raquel Rivera-Díaz, Frank Kolbinger, ManikPrabhu Nanna, Jennifer Annika Frueh, Piotr Jagiello
Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Fabio Verardi, Lara Valeska Maul, Kim Borsky, Simona Steinmann, Nina Rosset, Hector Ortega Pons, Christina Sorbe, Nikhil Yawalkar, Raphael Micheroli, Alexander Egeberg, Jacob P Thyssen, Kristine Heidemeyer, Wolf-Henning Boehncke, Curdin Conrad, Antonio Cozzio, Andreas Pinter, Thomas Kündig, Alexander A Navarini, Julia-Tatjana Maul
Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT). Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Nina Magnolo, Thomas Jaenicke, Athanasios Tsianakas, Wolfgang Czech, Diamant Thaҫi, Andreas Pinter, Delphine Kerob, Samir Salah, Thomas A Luger
Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Andreas Pinter, A Costanzo, S Khattri, S D Smith, J M Carrascosa, Y Tada, E Riedl, A Reich, A Brnabic, N Haustrup, A Lampropoulou, I Lipkovich, Z Kadziola, C Paul, C Schuster
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and therapy 14 (6) (2023)
Andreas Pinter, A Costanzo, S Khattri, S D Smith, J M Carrascosa, Y Tada, E Riedl, A Reich, A Brnabic, N Haustrup, A Lampropoulou, I Lipkovich, Z Kadziola, C Paul, C Schuster
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and therapy 14 (6) (2023)
Andreas Pinter, A Costanzo, S Khattri, S D Smith, J M Carrascosa, Y Tada, E Riedl, A Reich, A Brnabic, N Haustrup, A Lampropoulou, I Lipkovich, Z Kadziola, C Paul, C Schuster
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and therapy 14 (6) (2023)
Adam Reich, Andreas Pinter, Julia-Tatjana Maul, Ronald B Vender, Tiago Torres, A Brnabic, Natalie Haustrup, C Reed, C Schuster, E Riedl
Speed of Clinical Improvement in the Real-World Setting from Patient-Reported Psoriasis Symptoms and Signs Diary (PSSD): Secondary Outcomes from the Psoriasis Study of Health Outcomes (PSoHO) Through 12 Weeks. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Andreas Pinter, A Costanzo, S Khattri, S D Smith, J M Carrascosa, Y Tada, E Riedl, A Reich, A Brnabic, N Haustrup, A Lampropoulou, I Lipkovich, Z Kadziola, C Paul, C Schuster
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and therapy (2023)
Andreas Pinter, A Reich, Monika Arenbergerova, Linda F Stein Gold, A Armstrong, L Iversen, M Praestegaard, Matthias Augustin
Randomised Phase 3 trial demonstrating high efficacy, favourable safety, and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Nina Magnolo, Thomas Jaenicke, Athanasios Tsianakas, Wolfgang Czech, Diamant Thaҫi, Andreas Pinter, Delphine Kerob, Samir Salah, Thomas A Luger
Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Sebastian Kiefer, Anke König, Viviane Gerger, Christine Rummenigge, Anne Christine Müller, Thomas Jung, Alexandra Frank, Georgios Tassopoulos, Emilie Laurent, Roland Kaufmann, Andreas Pinter
Efficacy and Treatment Satisfaction of Different Systemic Therapies in Children and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Real-World Study. Journal of clinical medicine 12 (3) (2023)
Andreas Pinter, A Costanzo, S Khattri, S D Smith, J M Carrascosa, Y Tada, E Riedl, A Reich, A Brnabic, N Haustrup, A Lampropoulou, I Lipkovich, Z Kadziola, C Paul, C Schuster
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO). Dermatology and therapy (2023)
Sebastian Kiefer, Anke König, Viviane Gerger, Christine Rummenigge, Anne Christine Müller, Thomas Jung, Alexandra Frank, Georgios Tassopoulos, Emilie Laurent, Roland Kaufmann, Andreas Pinter
Efficacy and Treatment Satisfaction of Different Systemic Therapies in Children and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Real-World Study. Journal of clinical medicine 12 (3) (2023)
Natalia Kirsten, Frenz Ohm, Kathrin Gehrdau, Gefion Girbig, Brigitte Stephan, Nesrine Ben-Anaya, Andreas Pinter, Falk G Bechara, Dagmar Presser, Christos C Zouboulis, Matthias Augustin
Switching from Adalimumab Originator to Biosimilar in Patients with Hidradenitis Suppurativa Results in Losses of Response-Data from the German HS Registry HSBest. Life (Basel, Switzerland) 12 (10) (2022)
Andreas Pinter, Peter Cornelis Maria van de Kerkhof
The role of topical therapies along the psoriasis patient journey: An overview from the Symposium 'Tailoring topical psoriasis treatments to patients' needs and expectations' of the 30 th EADV Congress 2021. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Andreas Pinter, Lluis L Puig, Knut Schäkel, Adam Reich, Shirin Zaheri, Antonio Costanzo, Tsen Fang Tsai, Saxon D Smith, Charles Lynde, Alan Brnabic, Catherine Reed, Julie Hill, Christopher Schuster, Elisabeth Riedl, Carle Paul
Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO). Journal of the European Academy of Dermatology and Venereology : JEADV 36 (11) (2022)
Melinda J Gooderham, Andreas Pinter, L K Ferris, R B Warren, Tianyu Zhan, J Zeng, A M Soliman, C Kaufmann, B Kaplan, H Photowala, Bruce E Strober
Long-term, durable, absolute Psoriasis Area and Severity Index and health-related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate-to-severe plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (6) (2022)
Matthias Augustin, Kristian Reich, Paul Yamauchi, Andreas Pinter, Jerry Bagel, Swapnil Dahale, Ruquan You, Gerard Bruin, Jimena Djimopoulos, Bertrand Paguet, Pascal Charef, Manmath Patekar, Deborah Keefe
Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial. The British journal of dermatology 186 (6) (2022)
Andreas Pinter, Linda F Stein Gold, Adam Reich, Lawrence J Green, Morten Praestegaard, Johan Selmer, April W Armstrong, Anne Danø, Sunil Dhawan, Jordi Galván, Sandra Elkjaer Stallknecht, Paw Trebbien, Matthias Augustin
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30 th EADV Congress 2021. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Jonathan Ian Silverberg, David N Adam, Matthew Zirwas, Sunil Kalia, Jan Gutermuth, Andreas Pinter, Andrew E Pink, Andrea Chiricozzi, Sébastien Barbarot, Thomas Mark, Ann-Marie Tindberg, Stephan Weidinger
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis. American journal of clinical dermatology 23 (4) (2022)
Phoebe Wellmann, Christian Kromer, Ralf Siemer, Selina Klein, Johannes Mohr, Undine Lippert, Andreas Pinter, Dagmar Wilsmann-Theis, Rotraut Mössner
Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso. Vaccines 10 (7) (2022)
Andreas Pinter, Peter E H Schwarz, Sascha Gerdes, Jan C Simon, Anja Saalbach, James Rush, Nima Melzer, Thomas Kramps, Benjamin Häberle, Maximilian Reinhardt
Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial. Nutrients 13 (9) (2021)
Mahreen Ameen, Stephan Meller, Andreas Pinter, Neil H Shear, Angele Soria, null null
Perception and Experience of Biologic Therapy in Atopic Dermatitis: A Qualitative Focus Group Study of Physicians and Patients in Europe and Canada. Dermatology and therapy 11 (6) (2021)
A Dmitriev, A König, V Lang, S Diehl, R Kaufmann, Andreas Pinter, Claudia Buerger
mTORC1 - a potential player in the pathogenesis of hidradenitis suppurativa? Journal of the European Academy of Dermatology and Venereology : JEADV 35 (7) (2021)
Christian Kromer, Phoebe Wellmann, Ralf Siemer, Selina Klein, Johannes Mohr, Andreas Pinter, Dagmar Wilsmann-Theis, Rotraut Mössner
Influenza Vaccination in Psoriatic Patients-Epidemiology and Patient Perceptions: A German Multicenter Study (Vac-Pso). Vaccines 9 (8) (2021)
Jonathan Ian Silverberg, Andreas Pinter, A Alavi, C Lynde, Jean-David Bouaziz, Andreas Wollenberg, D F Murrell, S Alpizar, V Laquer, K Chaouche, F Ahmad, J M Armstrong, Christophe Piketty
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (7) (2021)
Diamant Thaҫi, Kilian Eyerich, Andreas Pinter, M Sebastian, K Unnebrink, S Rubant, D A Williams, P Weisenseel
Direct comparison of risankizumab and fumaric acid esters in systemic therapy-naïve patients with moderate-to-severe plaque psoriasis: a randomized controlled trial. The British journal of dermatology (2021)
D Thaçi, A M Soliman, K Eyerich, Andreas Pinter, M Sebastian, K Unnebrink, S Rubant, D A Williams, P Weisenseel
Patient-reported outcomes with risankizumab versus fumaric acid esters in systemic therapy-naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
Andreas Pinter, L J Green, J Selmer, M Praestegaard, Linda F Stein Gold, Matthias Augustin, null null
A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
A Leutz, Andreas Pinter, D Thaçi, Matthias Augustin, C Schuster, K Fotiou, H P Hundemer, D Saure, Ulrich Mrowietz, Kristian Reich
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment. The British journal of dermatology 184 (3) (2020)
Amy S Paller, M M B Seyger, G Alejandro Magariños, J Bagel, Andreas Pinter, J Cather, S Keller, C Rodriguez Capriles, R Gontijo Lima, G Gallo, C A Little, Emily Edson-Heredia, L Li, W Xu, Kim A Papp, null null
Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS). The British journal of dermatology 183 (2) (2020)
Andreas Pinter, Georgios Kokolakis, Juergen Rech, Mona H C Biermann, Benjamin M Häberle, Jan Multmeier, Maximilian Reinhardt
Hidradenitis Suppurativa and Concurrent Psoriasis: Comparison of Epidemiology, Comorbidity Profiles, and Risk Factors. Dermatology and therapy 10 (4) (2020)
Franziska Stenger, Anke König, Falk Ochsendorf, Roland Kaufmann, Andreas Pinter
Correct performance of subcutaneous injections in plaque psoriasis: comparison of trained and untrained patients with different application systems in routine clinical care. The Journal of dermatological treatment 32 (8) (2020)
Christian Kromer, Dagmar Wilsmann-Theis, S Gerdes, S Krebs, Andreas Pinter, S Philipp, Rotraut Mössner
Changing within the same class: efficacy of brodalumab in plaque psoriasis after treatment with an IL-17A blocker - a retrospective multicenter study. The Journal of dermatological treatment 32 (8) (2020)
Andreas Pinter, M Hoffmann, Kristian Reich, Matthias Augustin, K Kaplan, S D Gudjónsdóttir, T Delvin, Ulrich Mrowietz, null null
A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE). Journal of the European Academy of Dermatology and Venereology : JEADV 35 (3) (2020)
Andrew Blauvelt, C Leonardi, Boni E Elewski, J J Crowley, L C Guenther, Melinda J Gooderham, R G Langley, Ronald B Vender, Andreas Pinter, C E M Griffiths, Y Tada, H Elmaraghy, R G Lima, G Gallo, L Renda, Russel T Burge, S Y Park, B Zhu, Kim A Papp, null null
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial. The British journal of dermatology 184 (6) (2020)
Andreas Pinter, Nicole Mielke, Bartosz Malisiewicz, Roland Kaufmann, Anke König
Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey. Dermatology and therapy 10 (4) (2020)
Andreas Pinter, Dagmar Wilsmann-Theis, Wiebke K Peitsch, Rotraut Mössner
Interleukin-17 receptor A blockade with brodalumab in palmoplantar pustular psoriasis: Report on four cases. The Journal of dermatology 46 (5) (2019)